Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2009-011527-31-AT
EUCTR2009-011527-31-AT
Active, not recruiting
Not Applicable

Effect of Nebivolol on climacteric disorders in postmenopausal women: A pilot study

Medizinische Universität Wien, Univ.Klinik KIM II, Abteilung für Kardiologie0 sites60 target enrollmentOctober 13, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionspostmenopausal women
DrugsNOMEXOR 5 mg - TablettenIsoflavon 90 mg, Dragees

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
postmenopausal women
Sponsor
Medizinische Universität Wien, Univ.Klinik KIM II, Abteilung für Kardiologie
Enrollment
60
Status
Active, not recruiting
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 13, 2009
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
Medizinische Universität Wien, Univ.Klinik KIM II, Abteilung für Kardiologie

Eligibility Criteria

Inclusion Criteria

  • •Menopausal patients (estrogen \<20 pg/ml and FSH \>35 mIU/ml)
  • •The patients are sexually active
  • •The patients have hot flushes
  • •The patients have palpitations or extrasystoles
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Patients with COPD
  • •Patients with an AV\-block
  • •Patients with a bradycardia (meaning a heart rate \<50 beats per minute)
  • •Patients with hypotension (RR \<100/80 mmHg)
  • •Patients with a PAD (stage III, IV)
  • •Patients with Asthma
  • •Patients with Morbus Raynaud
  • •Patients with a carcinoma
  • •Patients, who have already been treated because of hypertension
  • •Patients, who receive hormone replacement therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Influence of Nebivolol on Postmenopausal WomenHot FlashesHeart RateBlood PressureEndostatinSexual Function
NCT01161823Medical University of Vienna60
Completed
Not Applicable
Palliative effect of climacteric disorder by using wave motion equipment &quot;RAYOCOMP&quot; (preliminary clinical trial)
JPRN-UMIN000048460Japan Clinical Trial Association2
Active, not recruiting
Phase 1
Effects Of The Administration Of Nebivolol Versus Carvedilol On Microcirculatory Endothelial Function, Arterial Stiffness And Wave Reflection In Healthy Volunteers” (NeCaMic-study) - NeCaMicMicrocirculatory Endothelial Function, Arterial Stiffness And Wave Reflection
EUCTR2009-014643-36-BEMENARINI Benelux NV/SA
Active, not recruiting
Not Applicable
Comparative effects of Nebivolol and Carvedilol on orthostatic hypotension in hypertensive patients with type 2 diabetes mellitus (DIANECA) - DIANECAOrthostatic hypotension in hypertensive patients with type 2 diabetes mellitusMedDRA version: 9.1Level: LLTClassification code 10031127Term: Orthostatic hypotension
EUCTR2007-004438-18-ATMenarini International Operation Luxembourg S.A.404
Active, not recruiting
Phase 1
Comparative effects of Nebivolol and Carvedilol on orthostatic hypotension in hypertensive patients with type 2 diabetes mellitus (DIANECA) - DIANECAOrthostatic hypotension in hypertensive patients with type 2 diabetes mellitusMedDRA version: 9.1Level: LLTClassification code 10031127Term: Orthostatic hypotension
EUCTR2007-004438-18-BEA. Menarini Farmaceutica Internazionale s.r.l.404